IRMD Stock — Iradimed Co

Iradimed Co (IRMD)

Updated October 16, 2026.

IRMD is a Stock. its distribution rate is 0.91%, its trailing-12-month yield is 1.44%. Dividend Vision Distribution Safety Score™ is 67/100 (Generally safe). Total return is 881.8% over the past 12.3 years, 509.1 points ahead of SPY at 372.7%.

Iradimed Corporation develops, manufactures, and sells magnetic resonance imaging (MRI) compatible medical devices, including intravenous infusion pump systems and patient vital signs monitoring systems used in hospitals and imaging centers worldwide. The company distributes a modest current yield on a quarterly basis. This company may appeal to investors seeking exposure to medical device innovation with a modest income component.

IRMD performance versus SPY

Price and return data through 2026-10-16.

Total return is 881.8% over the past 12.3 years, 509.1 points ahead of SPY at 372.7%. Over the past year its total return — price change plus distributions reinvested — is 17.7%. Its deepest 1-year drawdown was 21.8%.

IRMD key facts

Distribution Safety Score™

67 · Generally safe

Safety-Adjusted Yield

0.61%

Asset type

Stock

Asset class

Equity

Inception date

07/16/2014

Distribution rate

0.91%

Distribution frequency

Quarterly

Trailing yield

1.44%

Last close

$88.27 (as of 2026-10-16)

Market cap

$1,128,707,696

Average volume

78799.0

Dividend

$0.20

Ex-dividend date

08/14/2026

Payment date

08/28/2026

Beta

0.913

Payout ratio

57.6%

P/E ratio

49.31

Forward P/E

41.1523

EPS

$1.79

How Dividend Vision calculates yield and returns

Distribution rate (0.91%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (1.44%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

IRMD risks and drawbacks

IRMD's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 21.8%.

Who may consider IRMD — and who may not

It is a weaker fit for investors who need monthly cash flow (IRMD pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on IRMD

• All tickers starting with I

Tagged: Healthcare, Dividend.

Frequently asked questions